Introduction

A CrystEngComm one-day symposium on pharmaceutical polymorphism was held in London in November 2011. The purpose of RSC journal symposia is to bring together scientists in a stimulating and friendly environment that fosters collaborations between the researchers and the universities involved in the meetings. The CrystEngComm symposium featured a selection of lectures reflecting the academic and industrial breadth of the field of pharmaceutical polymorphism. Talks by internationally recognised researchers covered the following topics: solid form screening, selection and manufacturing; thermodynamics, phase diagrams, properties, characterization; structure prediction; and patents.

The symposium was supported by CrystEngComm, a journal at the forefront of the design and understanding of solid-state and crystalline materials, from RSC Publishing.

Venue and dates

The symposium took place on Friday 4th November at the Chemistry Centre at Burlington House, London, UK.         

Confirmed speakers

• Z. Jane Li, Boehringer Ingelheim, USA 
• Graeme Day, University of Cambridge, UK 
• Örn Almarsson, Alkermes Inc., USA 
• Ann Newman, Seventh Street Development Group, IN, USA 
• Ivo Rietveld, Universite Paris Descartes, France 
• Jamshed Anwar, University of Bradford, UK
• Simon Black, Astra Zeneca, UK     
• Avijit Kelkar, Dr Reddy's Laboratories (UK) Limited, UK          

Exhibitor

Cambridge Crystallographic Data Centre (CCDC) exhibited at the symposium.